Sarcopenia Treatment Market

By region, Asia-Pacific is expected to experience a growth at the highest rate, registering a CAGR of 7.5% during the forecast period.

WILMINGTON, DELAWARE , UNITED STATES, June 12, 2024 /EINPresswire.com/ -- According to a new report published by Allied Market Research, titled, “Sarcopenia treatment market by treatment, route of administration, and distribution channel: global opportunity analysis and industry forecast, 2021–2030," The global sarcopenia treatment market size was valued at $2,577 million in 2020, and is projected to reach $4,704 million by 2030, registering a CAGR of 6.1% from 2021 to 2030.

The disease known as sarcopenia is characterized by the loss of skeletal muscle mass and strength. While it is largely an illness of the aged, diseases other than those that only affect the elderly may be linked to its development. Sarcopenia is a disorder that affects physical activity levels. Common symptoms include poor muscle mass or progressive loss, overall weakness, and decreased endurance. Reduced levels of physical exercise also have a role in the atrophy of muscles.

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐑𝐞𝐩𝐨𝐫𝐭 https://www.alliedmarketresearch.com/request-sample/A10526

The increasing prevalence of the aged population and the expanding use of vitamins and nutritional supplements are two major factors that are anticipated to propel the expansion of the market for sarcopenia treatments over the forecast period. The market for sarcopenia treatments is also expected to grow as a result of the predicted rise in sarcopenia cases. Also, increase in R&D activities for the treatment of sarcopenia is further projected to support the growth of the sarcopenia treatment market. Furthermore, an increase in malnutrition cases brought on by inadequate dietary intake may present more growth prospects for the sarcopenia therapy industry in the years to come.

The market is divided into categories based on treatments, such as protein supplements, vitamin B12 supplements, and supplements for calcium and vitamin D. As of 2020, the segment that sells protein supplements was the largest worldwide market, and it is expected that this trend would hold during the projected period. The global prevalence of nutritional deficiency has increased, and research and development efforts for new treatments, medications, and supplements are predicted to fuel the market for sarcopenia treatments.

𝐊𝐞𝐲 𝐅𝐢𝐧𝐝𝐢𝐧𝐠𝐬 𝐎𝐟 𝐓𝐡𝐞 𝐒𝐭𝐮𝐝𝐲
By treatment, the protein supplement segment witnessed the highest growth with a CAGR of 5.9% in the global sarcopenia treatment market in 2020.
By route of administration, the oral segment held the largest market share in 2020 and is expected to remain dominant throughout the forecast period.
By distribution channel, the hospital pharmacies segment exhibits the fastest growth and is expected to grow at a CAGR of 5.5% from 2021 to 2030.
By region, Asia-Pacific is expected to experience a growth at the highest rate, registering a CAGR of 7.5% during the forecast period.

𝐅𝐨𝐫 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐈𝐧𝐪𝐮𝐢𝐫𝐲- https://www.alliedmarketresearch.com/purchase-enquiry/A10526

𝐊𝐞𝐲 𝐁𝐞𝐧𝐞𝐟𝐢𝐭𝐬 𝐅𝐨𝐫 𝐒𝐭𝐚𝐤𝐞𝐡𝐨𝐥𝐝𝐞𝐫𝐬
The study provides an in-depth analysis of the sterilization services market size along with the current trends and future estimations to elucidate the imminent investment pockets.
It offers sarcopenia treatment market analysis from 2020 to 2030, which is expected to enable the stakeholders to capitalize on the prevailing opportunities in the market.
A comprehensive analysis of four regions is provided to determine the prevailing opportunities.
The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook and global sarcopenia treatment market growth.

𝐊𝐞𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐏𝐥𝐚𝐲𝐞𝐫𝐬
American Way (Amway) Corporation
Sanofi, Inc.
GlaxoSmithKline plc.
Nestle S.A.
Bayer AG
Pfizer, Inc.
Novartis AG
Zydus Cadila, Ltd.
F-Hoffmann La-Roche
Abbott Laboratories, Inc.

𝐎𝐭𝐡𝐞𝐫 𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 𝐢𝐧 𝐋𝐢𝐟𝐞 𝐒𝐜𝐢𝐞𝐧𝐜𝐞 𝐃𝐨𝐦𝐚𝐢𝐧
𝐓𝐮𝐦𝐨𝐫 𝐀𝐛𝐥𝐚𝐭𝐢𝐨𝐧 𝐦𝐚𝐫𝐤𝐞𝐭 https://www.alliedmarketresearch.com/tumor-ablation-market-A17208
𝐁𝐨𝐯𝐢𝐧𝐞 𝐌𝐚𝐬𝐭𝐢𝐭𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 https://www.alliedmarketresearch.com/bovine-mastitis-market-A17539

David Correa
Allied Market Research
+ 18007925285
email us here
Visit us on social media:
Facebook
Twitter

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.